Literature DB >> 2466580

Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. III. Antimetabolites, tubulin-binding agents, platinum drugs, amsacrine, L-asparaginase, interferons, steroids and other miscellaneous antitumor agents.

A G Bosanquet1.   

Abstract

The stability of solutions of the antitumour antimetabolites, vinca alkaloids, podophyllotoxins, interferons, steroids and platinum drugs as well as maytansine, asparaginase, amsacrine, flavone-8-acetic acid, mitoguazone, and N-phosphonoacetyl-L-aspartate (PALA) is reviewed. Much of the published work has been done with biological, not stability-indicating, assays; thus, the relevant results should be used with caution. With this proviso, almost all of these drugs can be stored in solution for several days at room temperature or 4 degrees C. Most reports also suggest that the drugs that have been tested are stable when frozen in solution. For a number of the drugs, particular precautions are required; for instance, amsacrine should not be mixed with chloride-containing solutions, whereas cisplatin is most stable in solutions containing greater than 0.1 M chloride.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466580     DOI: 10.1007/bf00451642

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  130 in total

1.  Room temperature stability of drug products labeled for refrigerated storage.

Authors:  R R Wolfert; R M Cox
Journal:  Am J Hosp Pharm       Date:  1975-06

2.  Stability of injectable medications after reconstitution.

Authors:  B E Kirschenbaum; C J Latiolas
Journal:  Am J Hosp Pharm       Date:  1976-08

Review 3.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Sensitive gas-liquid chromatographic assay of underivatized 5-fluorouracil in plasma.

Authors:  O Driessen; D de Vos; P J Timmermans
Journal:  J Chromatogr       Date:  1979-03-01

5.  Photosensitization by methotrexate photoproducts.

Authors:  C Chahidi; P Morliere; M Aubailly; L Dubertret; R Santus
Journal:  Photochem Photobiol       Date:  1983-09       Impact factor: 3.421

6.  The stability of five chemotherapy drugs stored frozen for use in the human tumor stem cell assay.

Authors:  R Franco; T Miller; T Kraft; M Popp; O Martelo
Journal:  Int J Cell Cloning       Date:  1985-11

7.  High-performance liquid chromatographic assay for cytosine arabinoside, uracil arabinoside and some related nucleosides.

Authors:  J A Sinkule; W E Evans
Journal:  J Chromatogr       Date:  1983-05-13

8.  Stability of cancer chemotherapeutic agents in a totally implanted drug delivery system.

Authors:  J H Keller; W D Ensminger
Journal:  Am J Hosp Pharm       Date:  1982-08

9.  Prednisolone disposition in obese men.

Authors:  R L Milsap; K I Plaisance; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1984-12       Impact factor: 6.875

10.  Antitumor activity and toxicity of serum protein-bound platinum formed from cisplatin.

Authors:  K Takahashi; T Seki; K Nishikawa; S Minamide; M Iwabuchi; M Ono; S Nagamine; H Horinishi
Journal:  Jpn J Cancer Res       Date:  1985-01
View more
  3 in total

1.  Carcinoembryonic Antigen Expression and Resistance to Radiation and 5-Fluorouracil-Induced Apoptosis and Autophagy.

Authors:  Ebrahim Eftekhar; Hajar Jaberie; Fakhraddin Naghibalhossaini
Journal:  Int J Mol Cell Med       Date:  2016-05-17

2.  E. coli-Derived L-Asparaginase Retains Enzymatic and Cytotoxic Activity In Vitro for Canine and Feline Lymphoma after Cold Storage.

Authors:  Jackie M Wypij; Holly C Pondenis
Journal:  Vet Med Int       Date:  2013-04-28

3.  5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins.

Authors:  M E Nita; H Nagawa; O Tominaga; N Tsuno; S Fujii; S Sasaki; C G Fu; T Takenoue; T Tsuruo; T Muto
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.